A randomized phase II trial assessing irinotecan (IRI) and 5FU/folinic acid (LV), “Mayo regimen”, in first line palliative chemotherapy patients (pts) with metastatic colorectal cancer (MCRC)

Carmelo Pozzo, Seppo Pyrhönen, I. Bodrogi, J. Szántó, H. Kamica-Mlodkowska, H. Starkammar, József Izsó, Per Krogh Hansen, Naysha Noel, G. Gruia,

European Journal of Cancer · 1999 · 11 citations · 0 references

Concepts